Viewing Study NCT04645160

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-05-07 @ 11:59 AM
Study NCT ID: NCT04645160
Status: RECRUITING
Last Update Posted: 2025-12-15
First Post: 2020-11-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cholangiocarcinoma View
None Bile Duct Neoplasm View
None Biliary Tract Malignancy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CCA View
None FOTIVDA View
None pan-vascular endothelial growth factor receptor (VEGFR) inhibitor View
None XPO7 View
None Ste-20 like kinase (SLK) View